This website uses cookies. For more information, please see our Privacy Policy. To accept cookies from this website please click Allow

JavaScript seems to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.

About OvuSense
Testimonials
Clinically Proven
Customer Support
Blog
Knowledge Hub
STORE
(0)

Clinical References

Arici A, Carr BR (1992) Comparison of two LH monitoring methods in women undergoing intrauterine insemination. Proceedings of the 48th Annual Meeting of the American Fertility Society.
American Society for Reproductive Medicine (ASRM) (2006) Effectiveness and treatment for unexplained infertility. Fertil Steril 86:4.
American Society for Reproductive Medicine (ASRM) (2012) Diagnostic evaluation of the infertile female. Fertil Steril 98: 2 302–307.
American Society for Reproductive Medicine (ASRM) (2013) Optimizing natural fertility. Fertil Steril 100:631-7.
American Society for Reproductive Medicine - Reproductive Facts www.reproductivefacts.org
Baird D, McConnaughey D (1995) Application of a method for estimating day of ovulation using urinary estrogen and Progesterone metabolites. Epidemiology 6:547-550
Balen A, Conway G, Kaltsas G (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod. 10:2107–2111.
Barrett JC Marshall J (1969) The risk of conception on different days of the menstrual cycle. Popul Stud (Camb), 23(3):455–461, Nov 1969.
Barron M L Fehring R (2005) Basal Body Temperature Assessment: Is It Useful to Couples Seeking Pregnancy? MCN Am J Matern Child Nurs. 30,5: 290-296
Barton M, Wiesner BP (1945) Thermogenic effect of Progesterone. Lancet 2:671
Bauman JE (1981) Basal body temperature: unreliable method of ovulation detection. Fertil Steril 36:729-733
Centers for Disease Control (2007, 2011) Assisted Reproductive Technology: Fertility Clinic Success Rates Report
Ciotta L, De Leo V et al. (1999) Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia. Hum Rep vol. 14, no 12, pp 2951-2958
Clayton RN, Ogden V, Hodgkinson J et al. (1992) How common are the polycystic ovaries in normal women and what is their significance for the fertility of the population? Clin. Endocrinol., 37, 127-134.
Colombo B, Masarotto G (2000) Daily fecundability: first results from a new data base. Demogr Res 3: article 5.
Coyne MD, Kesick CM (2000) Circadian rhythm changes in core temperature over the menstrual cycle: method for noninvasive monitoring. Am J Physiol Regul Integr Comp Physiol 279:R1316-R1320
Dale PO, Tanbo T (1992) Persistence in polycystic ovary syndrome after ovarian suppression by gonadotropin-releasing hormone agonist. Acta Endocrinol 126:132-6.
Dunson DB, Baird DD, Wilcox AJ, Weinberg CR (1999) Day-specific probabilities of clinical pregnancy based on two studies with imperfect measures of ovulation. Hum.Reprod., 14, (7) 1835-1839 available from: PM:10402400
Doring G (1969) The incidence of annular cycles in women. J Reprod Fertil, 6, pp.77-81.
ESHRE (2014). ART Fact Sheet. Eurpoean Society for Human Reproductive Endocrinology. July 2014.
Farquhar CM, Birdsall M, Manning P et al. (1994) The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Aust. NZ J. Obstet. Gynaecol., 34, 67-72.
Frank-Herrmann P, Gnoth C (2005) Determination of the fertile window: reproductive competence of women - European cycle databases. Gynecol Endocrinol 20:305-312
Freis A, Freundl-Schütt T (2018) Plausibility of Menstrual Cycle Apps Claiming to Support Conception. Front Public Health; 6: 98.
Freundl G, Godehardt E (2003) Estimated maximum failure rates of cycle monitors using daily conception probabilities in the menstrual cycle. Hum Rep 18:2628-32.
Heape W (1898) On Menstruation and Ovulation in Monkeys and in the Human Female BMJ Dec 24
HFEA (2013) Fertility Treatment in 2013: Trends and Figures. Human Fertilisation and Embryology Authority UK
HFEA Fertility Facts Human Fertilisation and Embryology Authority
Irons DW, Singh M (1994) Evaluation of transvaginal sonography combined with a urinary luteinizing hormone monitor in timing donor insemination. Hum Rep 9:1859-62.
Jukic A, Weinberg C, Baird D and Wilcox A (2007) Lifestyle and Reproductive Factors Associated with Follicular Phase Length. J Womens Health, 16(9), pp.1340-1347.
Klein N, Harper A (2002) Is the Short Follicular Phase in Older Women Secondary to Advanced or Accelerated Dominant Follicle Development?. J Clin Endocrinol Metab, 87(12), pp.5746-5750.
Kousta E, White DM (1999) The prevalence of polycystic ovaries in women with infertility. Hum Rep 14.11:2720-3.
Lenton EA, Landgren BM (1984) Normal variation in the length of the luteal phase of the menstrual cycle: identification of the short luteal phase. Br J Obstet Gynaecol 91:685-9.
Lenton EA, Landgren BM (1984) Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. Br J Obstet Gynaecol 91:681-4.
Lloyd R, Coulman CB (1989) The accuracy of urinary luteinising hormone testing in predicting ovulation. Am J Obstet Gynecol, 60:1370-2.
Luesley D, Baker P (2010) Obstetrics and Gynaecology: An Evidence-based Text for MRCOG. Hodder Arnold.
March WA, Moore VM (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Rep 25:544–51.
McCarthey and Rockette (1983) A comparison of methods to interpret the basal body temperature graph. Fertil Steril 39(5):6
McGovern PG, Myers ER (2004) Absence of secretory endometrium after false-positive home urine luteinizing hormone testing. Fertil Steril 82:5.
Moglia ML, Nguyen HV (2016) Evaluation of Smartphone Menstrual Cycle Tracking Applications Using an Adapted APPLICATIONS Scoring System. Obstet Gynecol 2016 Jun;127(6):1153-60
Mu Q and Fehring R (2014) Efficacy of achieving pregnancy with fertility-focused intercourse. MCN: The American Journal of Maternal Child Nursing 39: 35–40.
National Institute of Clinical Excellence (NICE): (2004). Fertility Assessment and Treatment of people with fertility problems. RCOG Press
Panaino T, da Silva J (2017) High Progesterone levels in the beginning of ICSI antagonist cycles and clinical pregnancy: still a concern? JBRA Assist Reprod. 2017 Jan-Mar; 21(1): 11–14.
Papaioannou S, Delkos D, Pardey J (2014) Vaginal core body temperature assessment identifies pre-ovulatory body temperature rise and detects ovulation in advance of ultrasound folliculometry. European Society of Human Reproduction and Embryology 30th Annual Conference.
Papaioannou S, Aslam M (2013) Quality Index assessment of vaginal temperature based fertility prediction and comparison with LH testing, ultrasound folliculometry and other home cycle monitors. American Society for Reproductive Medicine 69th Annual conference.
Papaioannou S, Aslam M (2013) User’s acceptability of Ovusense: a novel vaginal temperature sensor for prediction of the fertile period. J Obstet Gynaecol 33:705–9.
Papaioannou S, Aslam M (2012) Ovulation assessment by vaginal temperature analysis (Ovusense Fertility Monitoring System) in comparison to oral temperature recording. American Society for Reproductive Medicine 68th Annual conference.
Papaioannou S, Aslam M (2012) Ovulation Assessment and Fertile Period Prediction by Portable Computerised Vaginal Temperature Analysis – The OvuSense Advanced Fertility Monitoring System. European Society of Human Reproduction and Embryology 28th Annual Conference.
Polson DW, Adams J, Wadsworth J et al. (1988) Polycystic ovaries—a common finding in normal women. Lancet, i, 870-872.
Reproductive Medicine Associates of New Jersey (2015) Infertility in America 2015: Survey and Report.
Resolve - The Costs of Infertility Treatment: www.resolve.org
Rollason JCB, Outtrim JG, Mathur RS (2014) A pilot study comparing the DuoFertility monitor with ultrasound in infertile women IJWH 6 657-662
Robinson S, Rodin DA (1992) Which hormone tests for the diagnosis of polycystic ovary syndrome? Br J Obstet Gynaecol 99: 232–238
Royston P, Ferreira A (1999) A new approach to modeling daily probabilities of conception. Biometrics 55:1005-1013
Schwartz D, Mayaux MJ (1979) Donor insemination: conception rate according to cycle day in a series of 821 cycles with a single insemination. Fertil Steril 31:226-229
Shilaih M, Goodale B (2018) Modern fertility awareness methods: wrist wearables capture the changes in temperature associated with the menstrual cycle Bioscience Reports Nov 30, 2018 38 (6) BSR20171279
Setton R, Tierney C, Tsai T (2016) The accuracy of websites and cellular phone applications in predicting the fertile window. Obstet Gynecol 2016 Jun 6
Sirmans S, Pate K (2013) Epidemiology, diagnosis, and management of polycystic ovary syndrome. J Clin Epidemiol 2014: 6
Teede H, Deeks A (2010) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic, manifestations that impacts on health across the lifespan. BMC Medicine 2010, 8:41
Vlaisavljević V, Došen M (2007) Clinical Applications of Ultrasound in Assessment of Follicle Development and Growth. Donald School Journal of Ultrasound in Obstetrics and Gynecology. 1(20):50-63.
Wallace WHB, Kelsey TW (2010) Human Ovarian Reserve from Conception to the Menopause. PLoS ONE 5(1): e8772. doi:10.1371/journal.pone.0008772
Weinberg CR, Gladen BC (1994) Models relating the timing of intercourse to the probability of conception and the sex of the baby. Biometrics 50:358-367
Wilcox AJ, Dunson D (2000) The timing of the "fertile window" in the menstrual cycle: day specific estimates from a prospective study. BMJ 321:1259-62.
Wise LA, Hatch EE (2015) A randomized trial of web-based fertility-tracking software and fecundability. Fertil Steril Volume 104, Issue 3, Supplement, Page e113
Zuspan FP, Rao P (1974) Thermogenic alterations in the woman. Interaction of amines, ovulation, and basal body temperature. Am.J Obstet Gynecol 118:671-678

PCOS
PCOS and Medications
Trying 6+ months?
Cycle Characteristics
Affiliate Programme
Compare fertility testing methods

FAQs
Approvals
Clinically Proven
Clinical References
Clinician Contact Form

Contact Us
The OvuSense Support Team
Privacy Policy
Terms & Conditions
Cancel a Subscription

Fertility Focus Inc, 283 Boston Post Road, Suite F, Old Saybrook, CT 06475, USA | Monday-Friday : 9:00 a.m. to 5:00 p.m. EST
Enquiries and technical support : click 'Customer Support' at the top of this page or call +1 855 688 1610 (voicemail)
US Patent Numbers 20050192512, 8496592, 9155522 and 9155523